MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-WB-06-0012076
Revanex Pharmaceuticals Private Limited
Revanex Pharmaceuticals Private Limited - chemicals in Siliguri, West Bengal, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.25 Cr
▲ 187% YoY
Net profit · FY 2025
₹15.55 Lakh
Net margin 12.5%
EBITDA · FY 2025
₹22.58 Lakh
EBITDA margin 18.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Revanex Pharmaceuticals Private Limited
Data last updated:
Revanex Pharmaceuticals Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 September 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2022PTC257023.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kumari Kavita and Babita Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Uday Sankar Sarani Deshbandhu Para, Siliguri Darjeeling Siliguri(Po), West Bengal, India – 734004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.25 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹15.55 Lakh (net margin 12.5%) and EBITDA of ₹22.58 Lakh (EBITDA margin 18.1%).
Revanex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-06-0012076). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290WB2022PTC257023
Registration Number 257023
Incorporation Date 08 September 2022
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-06-0012076
Recognitions & Rankings of Revanex Pharmaceuticals
Contact details
Revanex Pharmaceuticals Private Limited's registered office is in Siliguri, West Bengal.
- Registered Address24 Uday Sankar Sarani Deshbandhu Para, Siliguri Darjeeling Siliguri(Po), West Bengal, India – 734004
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Revanex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Revanex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Revanex Pharmaceuticals Private Limited, buy the company report.
Financials of Revanex Pharmaceuticals Private Limited
FY 2025 filings availableRevanex Pharmaceuticals Private Limited reported revenue of ₹1.25 Cr (up 187% YoY) for FY 2025.
Revenue · FY 2025
₹1.25 Cr ▲ 187%
Net profit · FY 2025
₹15.55 Lakh margin 12.5%
EBITDA · FY 2025
₹22.58 Lakh margin 18.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 187%
EBITDA CAGR growth
1 year
▲ 190%
Revenue rose 187% in the latest year. EBITDA rose 190% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹22.58 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹15.55 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 18.1% | ||
| Net Profit Margin | 12.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Revanex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Revanex Pharmaceuticals Private Limited
Revanex Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kumari Kavita Also directs: Mansh Nephro Hospital Private Limited | Director | 08 Sep 2022 | 4 Years 2 Months | Current |
| Babita Kumari Also directs: Shausri Nephcare LLP | Director | 08 Sep 2022 | 4 Years 2 Months | Current |
| Mita Mukhertee Also directs: Alpharen Lifesciences Private Limited | Director | 08 Sep 2022 | 4 Years 2 Months | Current |
| Debopriya Bhadra Also directs: Alpharen Lifesciences Private Limited | Director | 25 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Revanex Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Demexico Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2024) | 5.0% | Dehradun, Uttarakhand, India | |||
| Meticue Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | 23.0% | New Delhi, Delhi, India | |||
| Zoydec Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 19.0% | Chandigarh, India | |||
| Revanex Pharmaceuticals Private Limitedthis company | ₹1.25 Cr (FY 2025) | ₹15.55 Lakh | 12.5% | 187.0% | Siliguri, West Bengal, India | |
| Bageo Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2022) | 45.0% | Salem, Tamil Nadu, India | |||
| Arushnova Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 37.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Revanex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Revanex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revanex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Revanex Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Revanex Pharmaceuticals Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Debopriya Bhadra was appointed as Director on 25 Aug 2024.
AGM
Revanex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Revanex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Appointed
Debopriya Bhadra was appointed as Director.
Ceased
Srimayee Bhadra ceased to be Director.
Appointed
Babita Kumari was appointed as Director.
Appointed
Kumari Kavita was appointed as Director.
Appointed
Mita Mukhertee was appointed as Director.
Incorporation
08 Sep 2022
Revanex Pharmaceuticals Private Limited was registered on 08 Sep 2022 with Roc Kolkata Ii & aged 4 years 2 months as per MCA records.
Frequently asked questions
Revanex Pharmaceuticals is an active private limited company based in Siliguri, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 September 2022 (4+ years old) and is registered under CIN U24290WB2022PTC257023.
Revanex Pharmaceuticals has 4 current directors:
- Kumari Kavita - Director
- Babita Kumari - Director
- Mita Mukhertee - Director
- Debopriya Bhadra - Director
The latest financial statements of Revanex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Revanex Pharmaceuticals is U24290WB2022PTC257023. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revanex Pharmaceuticals was incorporated on 08 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Revanex Pharmaceuticals by revenue are Demexico Pharmaceuticals Private Limited, Meticue Pharmaceuticals Private Limited, Zoydec Pharmaceuticals Private Limited, Bageo Pharmaceuticals Private Limited, Arushnova Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Debopriya Bhadra was appointed as Director on 25 Aug 2024. Srimayee Bhadra ceased to be Director on 25 Aug 2024. Babita Kumari was appointed as Director on 08 Sep 2022. Revanex Pharmaceuticals has 5 board changes on record in total.
Yes, Revanex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-06-0012076).
The registered office of Revanex Pharmaceuticals is at 24 Uday Sankar Sarani Deshbandhu Para, Siliguri Darjeeling SiliguriPo, West Bengal, India – 734004.
Revanex Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Revanex Pharmaceuticals is compliant as of 26 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages